Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Why Tracking Error Occurs
Tracking error arises from fees, sampling, and/index composition differences. This intro covers primary causes and practical mitigation ideas.
19,096 articles
Widow’s First Year Filing Could Raise Medicare Premiums
A widow’s first year filing solo can push Medicare premiums higher through IRMAA, potentially adding hundreds of doll...
Century CEO: Adding Latino Agents to Serve 70% Buyers
Century 21 Chief Executive Mike Miedler says recruiting more Latino agents is crucial to serving the majority of futu...
Helen Troy (HELE) 2027: Investing Outlook and Strategy
As investors eye helen troy (hele) 2027, the Q1 earnings call could reveal how branded consumer products, e-commerce ...
Meta Platforms Aiming Trillion: What Investors Must Know
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
Explainer: Micron Looks Cheaper Right Now for Investors
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
These Growth Sectors Helping People Flourish Draw Investors
Three growth sectors are reshaping everyday life and attracting patient, long-term capital as markets steady in 2026....
Rate Adds Loan Officers From New American Funding Team
Rate expands its mortgage team by bringing 14 loan officers from New American Funding, aiming to boost production and...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Nvidia Stock: What Investors Should Know After AI Deal
Nvidia just landed a significant AI deal that could shift its growth trajectory. This article breaks down what invest...
Wix Stock Drops After JPMorgan Downgrade Amid AI Threat
JPMorgan downgraded Wix.com to Underweight and cut its price target to $91, citing slower core growth and volatile ma...
IBB: Which IShares Healthcare ETF Is Right for You
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status